PCR assay for herpesviruses
Eye Care
estimated about CNY 400-800
Disclaimer: This site is a medical service platform; some page content is AI-assisted. Health-related information does not constitute medical advice. If you have any questions, please consult a healthcare professional. See full disclaimer
Description
A molecular diagnostic test using polymerase chain reaction to detect and quantify DNA from herpesviruses including HSV-1, HSV-2, VZV, and EBV in clinical specimens.
Main Uses
Diagnosis of acute or reactivated herpesvirus infections (HSV-1/2, VZV, EBV); monitoring viral load in immunocompromised patients; differentiating viral from non-viral CNS disorders (e.g., HSV encephalitis vs. autoimmune encephalitis); guiding antiviral therapy initiation and duration; assessing risk of EBV-driven lymphoproliferation post-transplant; confirming VZV reactivation in atypical zoster presentations.
Normal Range
Negative (no detectable viral DNA); quantitative results vary by assay and laboratory but typically reported as 'Not Detected' or <10–50 copies/mL for HSV, VZV, and EBV. Reference ranges depend on specimen type (e.g., CSF, plasma, whole blood, swab) and platform (e.g., real-time PCR). No universally defined 'normal' numerical range—interpretation is qualitative (detected/not detected) or semi-quantitative (viral load in log10 copies/mL with lab-specific cutoffs).
Low Values - Possible Causes
1. Absence of active viral infection; 2. Effective antiviral therapy suppressing replication; 3. Specimen collection error (e.g., inadequate sample volume, improper transport/storage leading to DNA degradation); 4. Low viral shedding or latent infection phase; 5. Inhibitors in the sample interfering with PCR amplification (e.g., heparin, hemoglobin, mucins).
High Values - Possible Causes
1. Active primary or reactivated herpesvirus infection (e.g., HSV encephalitis, VZV vasculopathy, EBV-associated post-transplant lymphoproliferative disorder); 2. Immunocompromised state (e.g., HIV/AIDS, hematopoietic stem cell transplant, solid organ transplant); 3. Disseminated or systemic viral disease; 4. Sample contamination (rare but possible with amplicon carryover); 5. High-titer viremia due to impaired immune clearance.
estimated about CNY 400-800
Related Items
Dry Eye Syndrome Treatment
estimated about CNY 200-1000
Phacoemulsification with intraocular lens implantation
estimated about CNY 8000-15000
Femtosecond laser-assisted cataract surgery (FLACS)
estimated about CNY 12000-22000
YAG laser capsulotomy
estimated about CNY 800-1500
Intravitreal injection of ranibizumab
estimated about CNY 5500-6500
Intravitreal injection of conbercept
estimated about CNY 3500-4500